Crossmark

Angiopoietin-like 4 promotes osteosarcoma cell proliferation and migration and stimulates osteoclastogenesis

Crossref DOI link: https://doi.org/10.1186/s12885-018-4468-5

Published Online: 2018-05-08

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, T.

Kastrenopoulou, A.

Larrouture, Q.

Athanasou, N. A.

Knowles, H. J. https://orcid.org/0000-0002-9575-6067
Funding

Funding for this research was provided by:

Arthritis Research UK (MP/19200)

Bone Cancer Research Trust

China Scholarship Council

National Institute for Health Research
License Information

Text and Data Mining valid from 2018-05-08
More Information

Article History

Received: 24 November 2017

Accepted: 30 April 2018

First Online: 8 May 2018

Ethics approval and consent to participate

: Samples were collected with informed written donor consent in full compliance with national and institutional ethical requirements, the United Kingdom Human Tissue Act and the Declaration of Helsinki. This study was approved by the Oxford Clinical Research Ethics Committee (C01.071). No ethical approval was required for use of the osteosarcoma cell lines.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.